Image uploaded from a quicklink (Image by Unknown Owner) Details DMCA | Doctors are less likely to trust research studies performed with funding from corporate interests such as pharmaceutical companies, according to a new study. The report, published this week in the New England Journal of Medicine, reveals a long-suspected bias against such research among physicians. It also demonstrates the price companies have paid for public violations of trust, including examples of data manipulation and misrepresentation of study results.
In the study, researchers from Harvard Medical School asked physicians to read abstracts from studies reporting promising clinical data about a couple of different new drugs. |